Biotech · Private company
Accendatech USA Inc.
Track this companyFree. Adds Accendatech USA Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- ACT001Phase 2 · Recurrent Glioblastoma Multiforme(GBM)ClinicalTrials.gov · fetched Nov 12, 2026
- ACT001 + PembrolizumabPhase 2 · Recurrent Glioblastoma Multiforme(GBM)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade GliomasPHASE2 · RECRUITING · started Jul 10, 2025ClinicalTrials.gov NCT06838676 · fetched Nov 12, 2026
- A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma MultiformePHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 22, 2021ClinicalTrials.gov NCT05053880 · fetched Nov 12, 2026